Two-miRNA classifiers differentiate mutation-negative follicular thyroid carcinomas and follicular thyroid adenomas in fine needle aspirations with high specificity
- 402 Downloads
Diagnosis of thyroid by fine needle aspiration is challenging for the “indeterminate” category and can be supported by molecular testing. We set out to identify miRNA markers that could be used in a diagnostic setting to improve the discrimination of mutation-negative indeterminate fine needle aspirations. miRNA high-throughput sequencing was performed for freshly frozen tissue samples of 19 RAS and PAX8/PPARG mutation-negative follicular thyroid carcinomas, and 23 RAS and PAX8/PPARG mutation-negative follicular adenomas. Differentially expressed miRNAs were validated by quantitative polymerase chain reaction in a set of 44 fine needle aspiration samples representing 24 follicular thyroid carcinomas and 20 follicular adenomas. Twenty-six miRNAs characterized by a significant differential expression between follicular thyroid carcinomas and follicular adenomas were identified. Nevertheless, since no single miRNA had satisfactory predictive power, classifiers comprising two differentially expressed miRNAs were designed with the aim to improve the classification. Six two-miRNA classifiers were established and quantitative polymerase chain reaction validated in fine needle aspiration samples. Four out of six classifiers were characterized by a high specificity (≥94 %). The best two-miRNA classifier (miR-484/miR-148b-3p) identified thyroid malignancy with a sensitivity of 89 % and a specificity of 87 %. The high-throughput sequencing allowed the identification of subtle differences in the miRNA expression profiles of follicular thyroid carcinomas and follicular adenomas. While none of the differentially expressed miRNAs could be used as a stand-alone malignancy marker, the validation results for two-miRNA classifiers in an independent set of fine needle aspirations are very promising. The ultimate evaluation of these classifiers for their capability of discriminating mutation-negative indeterminate fine needle aspirations will require the evaluation of a sufficiently large number of fine needle aspirations with histological confirmation.
KeywordsFollicular thyroid cancer Follicular thyroid adenoma High-throughput sequencing Classifier miRNA Fine needle aspiration cytology
The authors thank Eileen Bösenberg and Anja Moll for their excellent technical assistance. Dario Veneziano is thanked for suggestions related to bioinformatics analyses. This research was supported by the Foundation for Polish Science MPD program “Molecular Genomics, Transcriptomics and Bioinformatics in Cancer” carried by the School of Molecular Medicine at the Medical University of Warsaw (Tomasz Stokowy and Bartosz Wojtaś). Tomasz Stokowy is supported by the Bergen Medical Research Foundation (BMFS 807964). Laszlo Hegedüs is supported by an unrestricted grant from the Novo Nordisk Foundation. Ralf Paschke is supported by a DFG (PA423/14-1,2), a Deutsche Krebshilfe (109670), and a Wilhelm Sander Foundation (2013.010.1) grant. Markus Eszlinger is supported by a DFG (ES162/4-1), a Deutsche Krebshilfe (109994), and a Wilhelm Sander Foundation (2013.010.1) grant.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 1.H. Gharib, E. Papini, R. Paschke, D.S. Duick, R. Valcavi, L. Hegedus, P. Vitti, American Association of clinical endocrinologists, Italian Association of clinical endocrinologists and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr. Pract. 16, 1–43 (2010)CrossRefPubMedGoogle Scholar
- 3.B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel, Y.E. Nikiforov, F. Pacini, G.W. Randolph, A.M. Sawka, M. Schlumberger, K.G. Schuff, S.I. Sherman, J.A. Sosa, D.L. Steward, R.M. Tuttle, L. Wartofsky, 2015 American Thyroid Association Management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26, 1–133 (2016)CrossRefPubMedGoogle Scholar
- 4.Z.W. Baloch, V.A. LiVolsi, S.L. Asa, J. Rosai, M.J. Merino, G. Randolph, P. Vielh, R.M. DeMay, M.K. Sidawy, W.J. Frable, Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute thyroid fine-needle aspiration state of the science conference. Diagn. Cytopathol. 36, 425–437 (2008)CrossRefPubMedGoogle Scholar
- 10.T. Stokowy, B. Wojtas, K. Fujarewicz, B. Jarzab, M. Eszlinger, R. Paschke, miRNAs with the potential to distinguish follicular thyroid carcinomas from benign follicular thyroid tumors—results of a meta-analysis. Horm. Metab. Res. 46, 171–180 (2013)Google Scholar
- 12.Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell. 159, 676–690 (2014)Google Scholar
- 13.M. Swierniak, A. Wojcicka, M. Czetwertynska, E. Stachlewska, M. Maciag, W. Wiechno, B. Gornicka, M. Bogdanska, L. Koperski, A. de la Chapelle, K. Jazdzewski, In-depth characterization of the microRNA transcriptome in normal thyroid and papillary thyroid carcinoma. J. Clin. Endocrinol. Metab. 98, E1401–E1409 (2013)CrossRefPubMedGoogle Scholar
- 21.R.C. Gentleman, V.J. Carey, D.M. Bates, B. Bolstad, M. Dettling, S. Dudoit, B. Ellis, L. Gautier, Y. Ge, J. Gentry, K. Hornik, T. Hothorn, W. Huber, S. Iacus, R. Irizarry, F. Leisch, C. Li, M. Maechler, A.J. Rossini, G. Sawitzki, C. Smith, G. Smyth, L. Tierney, J.Y. Yang, J. Zhang, Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5, R80 (2004)CrossRefPubMedPubMedCentralGoogle Scholar
- 22.T. Stokowy, B. Wojtas, J. Krajewska, E. Stobiecka, H. Dralle, T. Musholt, S. Hauptmann, D. Lange, L. Hegedus, B. Jarzab, K. Krohn, R. Paschke, M. Eszlinger, A two miRNA classifier differentiates follicular thyroid carcinomas from follicular thyroid adenomas. Mol. Cell. Endocrinol. 399, 43–49 (2015)CrossRefPubMedGoogle Scholar
- 23.M. Eszlinger, A. Krogdahl, S. Munz, C. Rehfeld, E.M. Precht Jensen, C. Ferraz, E. Bosenberg, N. Drieschner, M. Scholz, L. Hegedus, R. Paschke, Impact of molecular screening for point mutations and rearrangements in routine air-dried fine-needle aspiration samples of thyroid nodules. Thyroid. 24, 305–313 (2014)CrossRefPubMedGoogle Scholar
- 24.C. Ferraz, C. Rehfeld, A. Krogdahl, E.M. Precht Jensen, E. Bosenberg, F. Narz, L. Hegedus, R. Paschke, M. Eszlinger, Detection of PAX8/PPARG and RET/PTC rearrangements is feasible in routine air-dried fine needle aspiration smears. Thyroid 22, 1025–1030 (2012)CrossRefPubMedPubMedCentralGoogle Scholar
- 27.Y.E. Nikiforov, N.P. Ohori, S.P. Hodak, S.E. Carty, S.O. LeBeau, R.L. Ferris, L. Yip, R.R. Seethala, M.E. Tublin, M.T. Stang, C. Coyne, J.T. Johnson, A.F. Stewart, M.N. Nikiforova, Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. J. Clin. Endocrinol. Metab. 96, 3390–3397 (2011)CrossRefPubMedPubMedCentralGoogle Scholar
- 28.M. Eszlinger, S. Piana, A. Moll, E. Bosenberg, A. Bisagni, A. Ciarrocchi, M. Ragazzi, R. Paschke, Molecular testing of thyroid fine needle aspirations (FNA) improves pre-surgical diagnosis and supports the histological identification of minimally invasive follicular thyroid carcinomas. Thyroid 25, 401–409 (2015)CrossRefPubMedGoogle Scholar